查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1563122

蓝色生物技术的全球市场：依产品、应用、最终用户和地区的预测（~2032年）

Global Blue Biotechnology Market Research Report Information by Product, by Application, and by End User and by Region - Forecast till 2032
出版日期: | 出版商: Market Research Future | 英文 131 Pages | 订单完成后即时交付

价格

蓝色生技市场规模预计将从2024年的56.5亿美元成长到2032年的105.4亿美元，预测期内年复合成长率为 7.15%。与源自海洋生物的药品和营养保健品相关的策略性举措以及基于蓝色生物技术的营养保健品和药品的意识不断增强等因素推动市场的成长。

提高对基于蓝色生物技术的营养保健品和药物的认识是同一市场成长的关键因素。随着消费者越来越意识到海鲜的健康益处，对海洋生物产品的需求也不断增加。含有 omega-3 脂肪酸、抗氧化剂和矿物质等海洋成分的膳食补充剂因其健康益处而变得越来越受欢迎。

区域洞察

由于研发活动投资增加、医疗保健基础设施改善以及成熟製药製造商在该地区的存在，2023年北美地区的市场占有率最大，约为 36.04%。

由于大量新兴公司的存在，预计欧洲市场在预测期内将大幅扩张。

由于农业、製药和化妆品等行业对海洋衍生产品的需求不断成长，预计亚太市场在预测期内将发展最快。此外，基因组学、蛋白质组学和代谢组学等生物技术工具和技术的改进使得研究和利用海洋资源变得更加容易，推动了市场成长。这些技术使研究人员能够更有效地检测、分离和提取海洋资源中的重要化学物质。

本报告调查了全球蓝色生物技术市场，提供了市场的定义和概述，市场成长的各种影响因素分析，市场规模推移和预测，各种区分、地区的细分，竞争环境，主要企业概况等彙整资料。

目录

第1章 执行摘要

第2章 市场概述

第3章 研究方法

第4章 市场动态

  • 促进因素
    • 提高人们对基于蓝色生物技术的营养补充剂和药物的认识
    • 增加与海洋生物基药物和营养保健品相关的策略性举措
  • 抑制因素
    • 严格的监理政策
  • 机会
    • 增加对基于生物技术的药物开发的投资

第5章 市场因素分析

  • 波特五力分析
  • 新冠肺炎（COVID-19）的影响

第6章 Global Blue 生技市场：依产品

  • 摘要
  • 酶
  • 医学
  • 大宗化学品
  • 生物聚合物
  • 其他

第7章 全球蓝色生技市场：依应用

  • 摘要
  • 生物工程
  • 基因体学
  • 疫苗开发
  • 药物发现
  • 渔业
  • 水产养殖
  • 生质燃料
  • 水处理服务
  • 其他

第8章 Global Blue 生技市场：依最终用户

  • 摘要
  • 医院
  • 製药公司
  • 生技公司
  • 其他

第9章 全球蓝色生技市场：依地区

  • 世界
  • 北美
  • 欧洲
  • 亚太地区
  • 其他领域

第10章 竞争态势

  • 摘要
  • 竞争基准测试
  • 主要成长策略
  • 开发专案数量最多的公司
  • 主要发展分析
  • 主要发展与成长策略
  • 主要公司的财务趋势

第11章 公司简介

  • MARINOMED BIOTECH AG
  • MARSHALL MARINE PRODUCTS/
  • MARINOVA
  • AKER BIOMARINE
  • PHARMAMAR
  • CYANOTECH CORPORATION
  • ADM
  • GEOMARINE BIOTECHNOLOGIES
  • CP KELCO U.S., INC.
  • TERSERA THERAPEUTICS LLC

第12章 附录

Product Code: MRFR/HC/0242-CR

Global Blue Biotechnology Market Research Report Information by Product (Enzymes, Pharma Products, Bulk Chemicals, and Others), by Application (Bioengineering, Genomics, Vaccine Development, Drug Discovery, Fisheries, Aquaculture, Biofuels, Water Treatment Services, and Others), and by End User (Hospitals, Pharmaceutical Companies, Biotechnology Companies, and Others) and by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2032

Market Overview

The Blue Biotechnology Market is expected to increase from USD 5.65 billion in 2024 to USD 10.54 billion by 2032, with a compound annual growth rate (CAGR) of 7.15% over the forecast period (2024-2032). The global market is being driven by increased awareness of blue biotechnology-based nutraceuticals and pharmaceuticals, as well as strategic initiatives involving medicines and nutraceuticals derived from marine creatures.

The growing awareness of blue biotechnology-based nutraceuticals and medicines is a key factor driving the blue biotechnology industry forward. As consumers become more aware of the health benefits of marine-derived substances, there is an increasing demand for items derived from marine species. Nutraceuticals containing marine components, such as omega-3 fatty acids, antioxidants, and minerals, are becoming increasingly popular due to their supposed health benefits.

Furthermore, a surge in strategic activities aiming at pharmaceutical and nutraceutical goods generated from marine organisms is propelling the Blue Biotechnology Market. As the pharmaceutical and nutraceutical companies seek new ways to address increasing healthcare and dietary demands, their attention has switched to the ocean's immense and largely unexplored resources.

Market Segment insights

The Blue Biotechnology Market is divided into several product categories, including enzymes, pharmaceuticals, bulk chemicals, biopolymers, and others.

The Blue Biotechnology Market is divided into several types, including bioengineering, genomics, vaccine development, drug research, fisheries, aquaculture, biofuels, water treatment services, and others.

The blue biotechnology market is divided into four end user segments: hospitals, pharmaceutical firms, biotechnology businesses, and others.

Regional insights

The market is segmented into four regions: North America, Europe, Asia-Pacific, and the rest of the world. North America had the biggest market share of approximately 36.04% in 2023, owing to increased investment in R&D activities, improved healthcare infrastructure, and the presence of established medication manufacturers in the region. Furthermore, the presence of well-known industry players who are actively involved in meeting consumer demand in the region is boosting the market's growth.

The European blue biotechnology market is expected to increase significantly during the forecast year, 2024-2032, due to the existence of numerous blue biotechnology start-ups. For example, the Calouste Gulbenkian and Oceano Azul Foundations, both based in Portugal, have received more than 120 blue biotechnology-related proposals from over 30 countries through September 2020.

The Asia-Pacific blue biotechnology market is expected to develop the quickest over the forecast period, driven by rising demand for marine-derived goods in industries such as agriculture, medicines, and cosmetics. Furthermore, improvements in biotechnological tools and techniques such as genomics, proteomics, and metabolomics have made it easier to research and use marine resources, resulting in increased market growth. These methods enable researchers to more efficiently detect, isolate, and extract important chemicals from marine species.

Major Players

Marinomed Biotech AG (Austria), Marshall Marine Products (India), Marinova (Australia), Aker BioMarine (Norway), Pharma Mar (Spain), Cyanotech Corporation (US), ADM (US), Geomarine (India), CP Kelco U.S., Inc. (US), and TerSera Therapeutics LLC (US) are among the key players in the Blue Biotechnology Market.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

  • 1.1 OVERVIEW

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE
  • 2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

  • 3.1 DATA MINING
  • 3.2 SECONDARY RESEARCH
  • 3.3 PRIMARY RESEARCH
  • 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
  • 3.5 FORECASTING TECHNIQUES
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
    • 3.6.1 BOTTOM-UP APPROACH
    • 3.6.2 TOP-DOWN APPROACH
  • 3.7 DATA TRIANGULATION
  • 3.8 VALIDATION

4 MARKET DYNAMICS

  • 4.1 OVERVIEW
  • 4.2 DRIVERS
    • 4.2.1 INCREASING AWARENESS OF BLUE BIOTECHNOLOGY-BASED NUTRACEUTICALS AND PHARMACEUTICALS
    • 4.2.2 RISING STRATEGIC INITIATIVES ASSOCIATED WITH PHARMACEUTICALS AND NUTRACEUTICALS SOURCED FROM MARINE ORGANISMS
  • 4.3 RESTRAINTS
    • 4.3.1 STRINGENT REGULATORY POLICIES
  • 4.4 OPPORTUNITIES
    • 4.4.1 INCREASING INVESTMENT IN THE DEVELOPMENT OF BIOTECHNOLOGY-BASED MEDICINE

5 MARKET FACTOR ANALYSIS

  • 5.1 PORTER'S FIVE FORCES MODEL
    • 5.1.1 THREAT OF NEW ENTRANTS
    • 5.1.2 BARGAINING POWER OF SUPPLIERS
    • 5.1.3 THREAT OF SUBSTITUTES
    • 5.1.4 BARGAINING POWER OF BUYERS
    • 5.1.5 INTENSITY OF RIVALRY
  • 5.2 IMPACT OF COVID-19 ON THE INDIA CELL CULTURE MEDIA MARKET
    • 5.2.1 IMPACT ON SUPPLY CHAIN

6 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY PRODUCT

  • 6.1 OVERVIEW
  • 6.2 ENZYMES
  • 6.3 PHARMA PRODUCTS
  • 6.4 BULK CHEMICALS
  • 6.5 BIOPOLYMERS
  • 6.6 OTHERS

7 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY APPLICATION

  • 7.1 OVERVIEW
  • 7.2 BIOENGINEERING
  • 7.3 GENOMICS
  • 7.4 VACCINE DEVELOPMENT
  • 7.5 DRUG DISCOVERY
  • 7.6 FISHERIES
  • 7.7 AQUACULTURE
  • 7.8 BIOFUELS
  • 7.9 WATER TREATMENT SERVICES
  • 7.10 OTHERS

8 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY END USER

  • 8.1 OVERVIEW
  • 8.2 HOSPITALS
  • 8.3 PHARMACEUTICAL COMPANIES
  • 8.4 BIOTECHNOLOGY COMPANIES
  • 8.5 OTHERS

9 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY REGION

  • 9.1 OVERVIEW
  • 9.2 NORTH AMERICA
    • 9.2.1 US
    • 9.2.2 CANADA
  • 9.3 EUROPE
    • 9.3.1 GERMANY
    • 9.3.2 FRANCE
    • 9.3.3 UK
    • 9.3.4 ITALY
    • 9.3.5 SPAIN
    • 9.3.6 NORWAY
    • 9.3.7 NETHERLANDS
    • 9.3.8 SWITZERLAND
    • 9.3.9 FINLAND
    • 9.3.10 BELGIUM
    • 9.3.11 REST OF EUROPE
  • 9.4 ASIA-PACIFIC
    • 9.4.1 CHINA
    • 9.4.2 INDIA
    • 9.4.3 JAPAN
    • 9.4.4 AUSTRALIA
    • 9.4.5 SOUTH KOREA
    • 9.4.6 REST OF ASIA-PACIFIC
  • 9.5 REST OF THE WORLD
    • 9.5.1 LATIN AMERICA
    • 9.5.2 MIDDLE EAST
    • 9.5.3 AFRICA

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 COMPETITIVE BENCHMARKING
  • 10.3 MAJOR GROWTH STRATEGY IN THE BLUE BIOTECHNOLOGY MARKET
  • 10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE BLUE BIOTECHNOLOGY MARKET
  • 10.5 KEY DEVELOPMENT ANALYSIS
  • 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 10.6.1 PRODUCT LAUNCH / PRODUCT APPROVAL
    • 10.6.2 AGREEMENT
    • 10.6.3 PARTNERSHIP
    • 10.6.4 ACQUISITION
  • 10.7 MAJOR PLAYERS FINANCIAL
    • 10.7.1 SALES (USD MILLION),
    • 10.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION),

11 COMPANY PROFILES

  • 11.1 MARINOMED BIOTECH AG
    • 11.1.1 COMPANY OVERVIEW
    • 11.1.2 FINANCIAL OVERVIEW
    • 11.1.3 PRODUCTS OFFERED
    • 11.1.4 KEY DEVELOPMENTS
    • 11.1.5 KEY STRATEGIES
  • 11.2 MARSHALL MARINE PRODUCTS/
    • 11.2.1 COMPANY OVERVIEW
    • 11.2.2 FINANCIAL OVERVIEW
    • 11.2.3 PRODUCTS OFFERED
    • 11.2.4 KEY DEVELOPMENTS
    • 11.2.5 KEY STRATEGIES
  • 11.3 MARINOVA
    • 11.3.1 COMPANY OVERVIEW
    • 11.3.2 FINANCIAL OVERVIEW
    • 11.3.3 PRODUCTS OFFERED
    • 11.3.4 KEY DEVELOPMENTS
    • 11.3.5 SWOT ANALYSIS
    • 11.3.6 KEY STRATEGIES
  • 11.4 AKER BIOMARINE
    • 11.4.1 COMPANY OVERVIEW
    • 11.4.2 FINANCIAL OVERVIEW
    • 11.4.3 PRODUCTS OFFERED
    • 11.4.4 KEY DEVELOPMENTS
    • 11.4.5 SWOT ANALYSIS
    • 11.4.6 KEY STRATEGIES
  • 11.5 PHARMAMAR
    • 11.5.1 COMPANY OVERVIEW
    • 11.5.2 FINANCIAL OVERVIEW
    • 11.5.3 PRODUCTS OFFERED
    • 11.5.4 KEY DEVELOPMENTS
    • 11.5.5 SWOT ANALYSIS
    • 11.5.6 KEY STRATEGIES
  • 11.6 CYANOTECH CORPORATION
    • 11.6.1 COMPANY OVERVIEWS
    • 11.6.2 FINANCIAL OVERVIEW
    • 11.6.3 PRODUCTS OFFERED
    • 11.6.4 KEY DEVELOPMENTS
    • 11.6.5 KEY STRATEGIES
  • 11.7 ADM
    • 11.7.1 COMPANY OVERVIEW
    • 11.7.2 FINANCIAL ANALYSIS
    • 11.7.3 PRODUCTS OFFERED
    • 11.7.4 KEY DEVELOPMENTS
    • 11.7.5 SWOT ANALYSIS
    • 11.7.6 KEY STRATEGIES
  • 11.8 GEOMARINE BIOTECHNOLOGIES
    • 11.8.1 COMPANY OVERVIEW
    • 11.8.2 FINANCIAL OVERVIEW
    • 11.8.3 PRODUCTS OFFERED
    • 11.8.4 KEY DEVELOPMENTS
    • 11.8.5 KEY STRATEGIES
  • 11.9 CP KELCO U.S., INC.
    • 11.9.1 COMPANY OVERVIEW
    • 11.9.2 FINANCIAL OVERVIEW
    • 11.9.3 PRODUCT OFFERED
    • 11.9.4 KEY DEVELOPMENTS
    • 11.9.5 KEY STRATEGIES
  • 11.10 TERSERA THERAPEUTICS LLC
    • 11.10.1 COMPANY OVERVIEW
    • 11.10.2 FINANCIAL OVERVIEW
    • 11.10.3 PRODUCTS OFFERED
    • 11.10.4 KEY DEVELOPMENTS
    • 11.10.5 SWOT ANALYSIS
    • 11.10.6 KEY STRATEGIES

12 APPENDIX

  • 12.1 REFERENCES
  • 12.2 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
  • TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • TABLE 3 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 4 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR ENZYMES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 5 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR PHARMA PRODUCTS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 6 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR BULK CHEMICALS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 7 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR BIOPOLYMERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 8 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 9 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 10 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR BIOENGINEERING, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 11 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR GENOMICS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 12 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR VACCINE DEVELOPMENT, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 13 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR DRUG DISCOVERY, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 14 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR FISHERIES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 15 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR AQUACULTURE, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 16 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR BIOFUELS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 17 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR WATER TREATMENT SERVICES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 18 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 19 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 20 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR HOSPITALS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 21 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR PHARMACEUTICAL COMPANIES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 22 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 23 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 24 NORTH AMERICA: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 25 NORTH AMERICA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 26 NORTH AMERICA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 27 NORTH AMERICA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 28 US: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 29 US: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 30 US: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 31 CANADA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 32 CANADA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 33 CANADA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 34 EUROPE: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 35 EUROPE: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 36 EUROPE: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 37 EUROPE: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 38 GERMANY: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 39 GERMANY: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 40 GERMANY: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 41 FRANCE: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 42 FRANCE: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 43 FRANCE: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 44 UK: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 45 UK: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 46 UK: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 47 ITALY: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 48 ITALY: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 49 ITALY: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 50 SPAIN: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 51 SPAIN: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 52 SPAIN: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 53 NORWAY: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 54 NORWAY: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 55 NORWAY: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 56 NETHERLANDS: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 57 NETHERLANDS: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 58 NETHERLANDS: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 59 SWITZERLAND: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 60 SWITZERLAND: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 61 SWITZERLAND: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 62 FINLAND: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 63 FINLAND: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 64 FINLAND: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 65 BELGIUM: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 66 BELGIUM: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 67 BELGIUM: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 68 REST OF EUROPE: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 69 REST OF EUROPE: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 70 REST OF EUROPE: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 71 ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 72 ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 73 ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 74 ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 75 CHINA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 76 CHINA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 77 CHINA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 78 INDIA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 79 INDIA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 80 INDIA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 81 JAPAN: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 82 JAPAN: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 83 JAPAN: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 84 AUSTRALIA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 85 AUSTRALIA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 86 AUSTRALIA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 87 SOUTH KOREA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 88 SOUTH KOREA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 89 SOUTH KOREA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 90 REST OF ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 91 REST OF ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 92 REST OF ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 93 REST OF THE WORLD: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 94 REST OF THE WORLD: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 95 REST OF THE WORLD: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 96 REST OF THE WORLD: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 97 LATIN AMERICA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 98 LATIN AMERICA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 99 LATIN AMERICA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 100 MIDDLE EAST: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 101 MIDDLE EAST: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 102 MIDDLE EAST: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 103 AFRICA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 104 AFRICA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 105 AFRICA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 106 MAJOR PLAYERS IN THE BLUE BIOTECHNOLOGY MARKET
  • TABLE 107 MOST ACTIVE PLAYER IN THE BLUE BIOTECHNOLOGY MARKET
  • TABLE 108 PRODUCT LAUNCH / PRODUCT APPROVAL
  • TABLE 109 AGREEMENT
  • TABLE 110 PARTNERSHIP
  • TABLE 111 ACQUISITION
  • TABLE 112 MARINOMED BIOTECH AG: PRODUCTS OFFERED
  • TABLE 113 MARINOMED BIOTECH AG: KEY DEVELOPMENTS
  • TABLE 114 MARSHALL MARINE PRODUCTS: PRODUCTS OFFERED
  • TABLE 115 MARINOVA: PRODUCTS OFFERED
  • TABLE 116 AKER BIOMARINE: PRODUCTS OFFERED
  • TABLE 117 AKER BIOMARINE.: KEY DEVELOPMENTS
  • TABLE 118 PHARMAMAR: PRODUCTS OFFERED
  • TABLE 119 PHARMAMAR: KEY DEVELOPMENTS
  • TABLE 120 CYANOTECH CORPORATION: PRODUCTS OFFERED
  • TABLE 121 CYANOTECH CORPORATION: KEY DEVELOPMENTS
  • TABLE 122 ADM: PRODUCTS OFFERED
  • TABLE 123 GEOMARINE BIOTECHNOLOGIES: PRODUCTS OFFERED
  • TABLE 124 CP KELCO U.S., INC.: PRODUCT OFFERED
  • TABLE 125 TERSERA THERAPEUTICS LLC: PRODUCTS OFFERED

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 GLOBAL BLUE BIOTECHNOLOGY MARKET
  • FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
  • FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE BLUE BIOTECHNOLOGY MARKET
  • FIGURE 5 DRIVER IMPACT ANALYSIS
  • FIGURE 6 RESTRAINT IMPACT ANALYSIS
  • FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: INDIA CELL CULTURE MEDIA MARKET
  • FIGURE 8 GLOBAL BLUE BIOTECHNOLOGY MARKET, PRODUCT SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION)
  • FIGURE 9 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2023 & 2032 (USD MILLION)
  • FIGURE 10 GLOBAL BLUE BIOTECHNOLOGY MARKET SHARE (%), BY PRODUCT,
  • FIGURE 11 GLOBAL BLUE BIOTECHNOLOGY MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION)
  • FIGURE 12 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2023 & 2032 (USD MILLION)
  • FIGURE 13 GLOBAL BLUE BIOTECHNOLOGY MARKET SHARE (%), BY APPLICATION,
  • FIGURE 14 GLOBAL BLUE BIOTECHNOLOGY MARKET, END USER SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION)
  • FIGURE 15 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY END USER, 2023 & 2032 (USD MILLION)
  • FIGURE 16 GLOBAL BLUE BIOTECHNOLOGY MARKET SHARE (%), BY END USER,
  • FIGURE 17 NORTH AMERICA MARKET ANALYSIS: BLUE BIOTECHNOLOGY MARKET, 2019-2032 (USD MILLION)
  • FIGURE 18 NORTH AMERICA: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 19 NORTH AMERICA: BLUE BIOTECHNOLOGY MARKET SHARE (%), BY COUNTRY,
  • FIGURE 20 EUROPE MARKET ANALYSIS: BLUE BIOTECHNOLOGY MARKET, 2019-2032 (USD MILLION)
  • FIGURE 21 EUROPE: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 22 EUROPE: BLUE BIOTECHNOLOGY MARKET SHARE (%), BY COUNTRY,
  • FIGURE 23 ASIA-PACIFIC MARKET ANALYSIS: BLUE BIOTECHNOLOGY MARKET, 2019-2032 (USD MILLION)
  • FIGURE 24 ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 25 ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET SHARE (%), BY COUNTRY,
  • FIGURE 26 REST OF THE WORLD MARKET ANALYSIS: BLUE BIOTECHNOLOGY MARKET, 2019-2032 (USD MILLION)
  • FIGURE 27 REST OF THE WORLD: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 28 REST OF THE WORLD: BLUE BIOTECHNOLOGY MARKET SHARE (%), BY COUNTRY,
  • FIGURE 29 BENCHMARKING OF MAJOR COMPETITORS
  • FIGURE 30 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE BLUE BIOTECHNOLOGY MARKET
  • FIGURE 31 BLUE BIOTECHNOLOGY MARKET: COMPETITIVE LANDSCAPE
  • FIGURE 32 MAJOR PLAYERS SALES (USD MILLION),
  • FIGURE 33 MAJOR PLAYER R&D EXPENDITURE (USD MILLION),
  • FIGURE 34 MARINOMED BIOTECH AG: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 35 MARINOVA: SWOT ANALYSIS
  • FIGURE 36 AKER BIOMARINE: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 37 AKER BIOMARINE: SWOT ANALYSIS
  • FIGURE 38 PHARMAMAR: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 39 PHARMAMAR: SWOT ANALYSIS
  • FIGURE 40 CYANOTECH CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 41 ADM: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 42 ADM: SWOT ANALYSIS
  • FIGURE 43 TERSERA THERAPEUTICS LLC: SWOT ANALYSIS